What Will Drive Medtronic’s Near-Term Growth

Medtronic recently posted its Q1 FY19 numbers, which were better than street estimates, led by a strong growth in the diabetes business. The company also revised its guidance upward, and expects strong growth in diabetes for the full year. We currently f https://www.forbes.com/sites/greatspeculations/2018/08/22/what-will-drive-medtronics-near-term-growth/#389bbd74dfb5